Arzamastev AP, Dorofeev VL, Konovalov AA, Kochin VYu, Lebedeva NN, Titov IV (2004). Determination of adulterated drugs by modern analytical teniques. Pharm. Chem. J. 38(3):166-169.
Crossref

Avbunudiogba JA, Erebor J, Cash –Torunarigha OE and Iwuagwu MA (2013). Evaluation of some commercially available brands of piroxicam capsules in the Nigeria market. Int. J. Pharm. Chem. Biol. Sci. 3(3):876-880.

Bansal D, Malla S, Gudala K, Tiwari P (2013). Anti-counterfeit technologies: A pharmaceutical industry perspective. Sci. Pharm. 81:1-13.
Crossref

British Pharmacopoeia (2015), London: The Pharmaceutical Press, Her Majesty's Stationary Office, 2015.

Cardot M, Beyssac E, Aleri M (2007). In vitro-in vivo correlation: importance of dissolution in IVIVC. Dissolut. Technol. 14(1):15-19.
Crossref

Deisingh AK (2005). Pharmaceutical counterfeiting. Analyst 130:271-279.
Crossref

Dewan SMR, Alam A, Ahmed SK (2013). A comparative quality control study on conventional ibuprofen tablets available in Bangladesh pharma market. Int. Res. Pharm. 4(1):96-98.

Eraga SO, Arhewoh MI, Chibuogwu RN and Iwuagwu MA (2015). A comparative UV-HPLC analysis of ten brands of ibuprofen tablets. Asian Pac. J. Trop. Biomed. 5(10):880-884.
Crossref

Esimone CO, Okoye FBC, Onah BU, Nworu CS, Omeje EO (2008). In-vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria. J. Vector Borne Dis. 45(1):60-65.

Giri TK, Manjusha (2013). Comparative in-vitro evaluation of conventional ibuprofen marketed formulation. J. Pharm. Sci. Technol. 2(2):75-80.

Karmakar P, Kibria G (2012). In-vitro comparative evaluation of quality control parameters between paracetamol and paracetamol/caffeine tablets available in Bangladesh. Int. Curr. Pharm. J. 1(5):103-109.
Crossref

Keledisis T, Keledisis I, Rafailidis PI, Falagas ME (2007). Counterfeit drugs: A Review of the scientific evidence. J. Antimicrob. Chemother. 60:214-236.
Crossref

Kulkarni KP, Mudit D, Selvam P, Ali SM (2011). Preparation and characterisation of freeze dried crystals of ibuprofen. Int. J. Pharm. 2(12):255-258.

Morris J, Stevens P (2006). Counterfeit Medicines in Less Developed Countries; Problems and Solutions. International Policy Network. London, UK. pp. 66-90.

Ngwaluka NC, Lawal K, Olurunfemi PO, Ochekpe NA (2009). Post-market in vitro bioequivalence study of six brands of ciprofloxacin tablets/capsule in Jos, Nigeria. Sci. Res. Essays 4(4):298-305.

Niharika G, Noor AVH, Sevukarajan M, Deepak P, Javeed K, Shaaz N, Shehnaz B (2013). Fabrication and characterisation of supramolecular assembly between ibuprofen and betacyclodextrins. Asian J. Pharm. Sci. Technol. 3(1):47-56.

Nsimba SED (2008). Problems associated with substandard and counterfeit drugs in developing countries: A review article on global implications of counterfeit drugs in the era of anti-retroviral (ARVs) drugs in a free market economy. East Afr. J. Public Health 5(3):205-210.

Okunlola A, Adegoke OA, Odeku OA (2009). Generic versus innovator: Analysis of the pharmaceutical qualities of paracetamol and ibuprofen tablets in the Nigerian market. East Afr. J. Pharm. Sci. 12:55-64.

Shah RY, Prajapati PN, Agrawal YK (2010). Anticountefeit packaging technologies. J. Adv. Pharm. Technol. 1(4):368-373.
Crossref

Sunaric S, Petkovic M, Denic M, Mitic S, Pavlovic A (2013). Determination of ibuprofen in combined dosage forms and cream by direct UV spectrophotometry after solid-phase extraction. Acta Poloniae Pharm. Drug Res. 70(3):401-411.

Teklu L, Adugna E, Ashenef A (2014). Quality Evaluation of Paracetamol Tablets Obtained From the Common Shops (Kiosks) In Addis Ababa, Ethiopia. Int. J. Pharm. Sci. Res. 5(9):3502-3510.

United States Pharmacopoeia and National Formulary USP 37 NF 32, The USP Convention Inc. 2015

WHO (World Health Organisation) (2014). Counterfeit Medicines, Factsheet 275, 

WHO (World Health Organization) (2006). General Information on counterfeit medicines, 2006.

Yankus W (2007). Counterfeit Drugs: Coming to a Pharmacy Near You. J. Pharm. Finan. Econ. Policy 16(3):3.